Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
about
Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosisThe role of visfatin in diabetic nephropathyPotential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis.Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver DiseaseRegulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin.Adipokines in Liver Cirrhosis.Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing.SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicityA key role for Pre-B cell colony-enhancing factor in experimental hepatitis.Modulatory effect of resveratrol on SIRT1, SIRT3, SIRT4, PGC1α and NAMPT gene expression profiles in wild-type adult zebrafish liver.
P2860
Q35169373-3FD0A80A-8EC6-40DF-8DD4-8135D282DBBDQ35656272-54DD8381-05D8-47B3-84CE-61D79CBF80C9Q35876759-E51D4B7D-B4F9-4797-9479-5A31F7B07C05Q36566846-486FE654-E9FF-4242-85A1-B627A04FDE7AQ37001197-90CC363B-AF2A-443E-BE5E-D3B8205245A4Q39195646-75AECF31-E4E0-4038-AE66-98844C366D52Q39404643-93C750B3-96F0-4F49-8EEB-9DEEC68B022EQ41909845-375DFDFA-99AB-4B74-A866-0B25CE612D70Q42006558-4F2975B4-4E5D-4CDA-A994-E5ADEBB2D5B3Q46776529-662C9596-2828-40B8-AECE-A78192D7CBC5Q54362738-32BCAFD4-CEF9-48C6-B3DB-5B0C96AA7C18
P2860
Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
@en
Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
@nl
type
label
Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
@en
Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
@nl
prefLabel
Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
@en
Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
@nl
P2093
P2860
P356
P1476
Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
@en
P2093
Jan Freark de Boer
Klaus H W Böker
Matthias J Bahr
Michael P Manns
Uwe J F Tietge
P2860
P304
P356
10.1152/AJPGI.00029.2008
P577
2008-12-12T00:00:00Z